FTC sues PE-backed anesthesia provider for monopolistic roll-ups, price setting
Fierce Healthcare
SEPTEMBER 21, 2023
Federal regulators have accused a major Texas-based anesthesia provider and its parent private equity firm of a decade-long, three-pronged scheme to suppress competition and drive-up prices. | U.S. Anesthesia Partners and Welsh, Carson, Anderson & Stowe, its private equity backer, have "cost Texans tens of millions of dollars more each year" by suppressing competition over the course of a decade, the regulator alleges.
Let's personalize your content